Washington, District of Columbia 20002


Anxiety Sensitivity Treatment for Heroin Users is a development project targeting mild and above levels of anxiety sensitivity that will involve the testing of a specialized protocol for improving treatment retention and outcomes for heroin dependent individuals in a residential substance use treatment. ASTH-HR will integrate established treatment modules such as Healthy Relationships, along with interoceptive exposure, affect management, and psycho-education exercises developed for anxiety prevention and treatment programs with standard substance use treatment.


Inclusion Criteria: - exhibit a score of 21 on a self-report measure of anxiety sensitivity - be in 28 days of residential substance use treatment. - meet criteria for current opioid dependence as determined by SCID interview administered at intake. Exclusion Criteria: - evidence of limited mental competency - the inability to give informed, voluntary, written consent to participate - current psychosis - current bipolar disorder.



Primary Contact:

Carl W Lejuez, PhD
Phone: (301)405-5932
Email: clejuez@psyc.umd.edu

Backup Contact:


Location Contact:

Washington, District of Columbia 20002
United States

Site Status: Recruiting

Data Source: ClinicalTrials.gov

Date Processed: August 31, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.